UOC
CPXX

UBS O'Connor’s CELATOR PHARMACEUTICALS INC. COMMON STOCK CPXX Stock Holding History

UBS O'Connor’s Portfolio CPXX Stock Details CPXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-336,115
Closed -$10.1M – 556
2016
Q2 		$10.1M Buy
+336,115
New +$6.82M 0.22% 119

UBS O'Connor's CPXX Position: Q3 2016 in Review

UBS O'Connor sold out of CELATOR PHARMACEUTICALS INC. COMMON STOCK (CPXX) in Q3 2016, closing a stake of 336,115 shares — an estimated $10.1M sold.

UBS O'Connor first reported a position in CPXX in Q2 2016 and held it in 1 quarter. The position peaked at $10.1M in Q2 2016. 0 funds tracked by Wall St. Rank hold CPXX as of Q3 2016.

  • UBS O'Connor reported no remaining CELATOR PHARMACEUTICALS INC. COMMON STOCK position as of Q3 2016 after selling out during the quarter.
  • UBS O'Connor sold 336,115 CELATOR PHARMACEUTICALS INC. COMMON STOCK shares in Q3 2016, an estimated $10.1M.
  • UBS O'Connor first reported a position in CELATOR PHARMACEUTICALS INC. COMMON STOCK in Q2 2016 and held it in 1 quarter.
  • UBS O'Connor's CELATOR PHARMACEUTICALS INC. COMMON STOCK position peaked at $10.1M in Q2 2016.
  • 0 funds tracked by Wall St. Rank held CELATOR PHARMACEUTICALS INC. COMMON STOCK as of Q3 2016.

Based on UBS O'Connor's 13F filing for Q3 2016, filed 14 Nov 2016.